Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs

Tucker, L, Allen, A, Chandler, D et al. (16 more authors) (2022) Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs. Rheumatology. keac260. ISSN 1462-0324

Metadata

Authors/Creators:
  • Tucker, L
  • Allen, A
  • Chandler, D
  • Ciurtin, C
  • Dick, A
  • Foulkes, A
  • Gullick, N
  • Helliwell, P ORCID logo https://orcid.org/0000-0002-4155-9105
  • Jadon, D
  • Jones, G
  • Kyle, S
  • Madhok, V
  • McHugh, N
  • Parkinson, A
  • Raine, T
  • Siebert, S
  • Smith, C
  • Tillett, W
  • Coates, LC
Keywords: PsA, biologics, targeted synthetic DMARDs, treatment, management, guideline, recommendations, psoriasis, enthesitis, dactylitis
Dates:
  • Accepted: 13 April 2022
  • Published (online): 31 May 2022
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 05 Aug 2022 13:24
Last Modified: 05 Aug 2022 13:24
Status: Published online
Publisher: Oxford University Press (OUP)
Identification Number: https://doi.org/10.1093/rheumatology/keac260
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)